Thioguanine, an underutilised option in inflammatory bowel disease?

被引:1
|
作者
Chetwood, John D. [1 ,2 ,5 ]
Paramsothy, Sudarshan [1 ,2 ,3 ,4 ]
Leong, Rupert W. [1 ,2 ,3 ,4 ]
机构
[1] Concord Repatriat Gen Hosp, Dept Gastroenterol & Hepatol, Sydney, Australia
[2] Univ Sydney, Concord Clin Sch, Sydney, Australia
[3] Macquarie Univ Hosp, Dept Gastroenterol, Sydney, NSW, Australia
[4] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia
[5] Concord Hosp, Hosp Rd, Sydney, NSW 2039, Australia
关键词
THERAPY;
D O I
10.1111/apt.17920
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This article is linked to Vasudevan et al papers. To view these articles, visit and
引用
收藏
页码:1009 / 1010
页数:2
相关论文
共 50 条
  • [1] Letter: Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply
    Vasudevan, Abhinav
    Con, Danny
    van Langenberg, Daniel R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (08) : 1011 - 1011
  • [2] Optimizing treatment with thioguanine derivatives in inflammatory bowel disease
    Louis, E
    Belaiche, J
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2003, 17 (01) : 37 - 46
  • [3] Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease
    Derijks, LJJ
    Gilissen, LPL
    Engels, LGJB
    Bos, LP
    Bus, PJ
    Lohman, JJHM
    van Deventer, SJH
    Hommes, DW
    Hooymans, PM
    THERAPEUTIC DRUG MONITORING, 2006, 28 (01) : 45 - 50
  • [4] Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review
    Berrie Meijer
    Chris JJ Mulder
    Godefridus J Peters
    Adriaan A van Bodegraven
    Nanne KH de Boer
    World Journal of Gastroenterology, 2016, 22 (40) : 9012 - 9021
  • [5] Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review
    Meijer, Berrie
    Mulder, Chris J. J.
    Peters, Godefridus J.
    van Bodegraven, Adriaan A.
    de Boer, Nanne K. H.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (40) : 9012 - 9021
  • [6] Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
    Crouwel, Femke
    Simsek, Melek
    de Boer, Marjon A.
    Mulder, Chris J. J.
    van Andel, Emma M.
    Creemers, Rob H.
    van Asseldonk, Dirk P.
    van Bodegraven, Ad A.
    Horjus, Carmen S.
    Visschedijk, Marijn C.
    Weusthuis, Angelique L. M.
    Seinen, Margien L.
    Jharap, Bindia
    van Schaik, Fiona D. M.
    Ahmad, Ishfaq
    Boekema, Paul J.
    Tack, Greetje J.
    Wormmeester, Louktje
    Lutgens, Maurice W. M. D.
    van Boeckel, Petra G. A.
    Gilissen, Lennard P. L.
    Kerkhof, Marjon
    Russel, Maurice G. V. M.
    Hoentjen, Frank
    Bartelink, Maartje E.
    Kuijvenhoven, Johan P.
    Maljaars, Jeroen W. J.
    van Dop, Willemijn A.
    Wonders, Janneke
    van der Voorn, Michael M. P. J. A.
    Buiter, Hans J. C.
    de Boer, Nanne K.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (05): : 738 - 745
  • [7] The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinic
    Smith, M.
    Blaker, P.
    Patel, C.
    Marinaki, A.
    Arenas, M.
    Escuredo, E.
    Anderson, S.
    Irving, P.
    Sanderson, J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (02) : 161 - 169
  • [8] Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease
    Qasim, Asghar
    McDonald, Sharon
    Sebastian, Shaji
    Mcloughlin, Ramona
    Buckley, Martin
    O'Connor, Humphrey
    O'Morain, Colm
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (02) : 194 - 199
  • [9] Thioguanine in inflammatory bowel disease: Long-term efficacy and safety
    Ward, Mark G.
    Patel, Kamal V.
    Kariyawasam, Viraj C.
    Goel, Rishi
    Warner, Ben
    Elliott, Tim R.
    Blaker, Paul A.
    Irving, Peter M.
    Marinaki, Anthony M.
    Sanderson, Jeremy D.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (04) : 563 - 570
  • [10] Apheresis in inflammatory bowel disease. a valid option?
    Luis Cabriada, Jose
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2012, 35 (01): : 22 - 31